Highly Potent Drugs

BioVectra Builds Fermentation and Complex Chemistry Facility in Nova Scotia

May 30, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.

Catalysis, Flow Chemistry Impact API Manufacturing

May 02, 2017

Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.

CMO Pfizer CentreOne Adds Highly Potent Solid Oral Dose to Portfolio

March 16, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Manufacturing will be carried out at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract manufacturing network.

Understanding Containment

March 02, 2017

The new ISPE Containment Manual is a summary of the process involved in the manufacture of highly active or highly hazardous pharmaceutical substances.

Symbiosis Announces Plans to Open US Office

February 16, 2017

The new commercial site, set to be located in Cambridge, Boston, MA, will serve clients on both the East and West Coast. It will also be the base for reaching new customers in the area.

Idifarma Reports Record Growth

November 08, 2016

Idifarma has announced a growth of more than 50% over the past two years. Revenue is expected to hit approximately EUR5.3 million in 2016, growing from EUR3.5 million in 2014.

PCI to Share Expertise in Serialization and Handling of Potent Drugs at CPhI

September 22, 2016

PCI will be participating in two Speakers Corner slots at the ICSE Exhibitor Showcase.

Alcami Expands US API Capacity

August 18, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

CDMO Alcami adds HPAPI capacity and cryogenic capabilities to its Wisconsin facility.

Piramal to Acquire HPAPI CDMO Ash Stevens

August 16, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.

Designing Flexible Aseptic Containment Systems

August 02, 2016

The design of Baxter BioPharma Solutions’ aseptic filling lines provides a case study in customizing containment systems for multi-product lines